Physician profile
Joseph E Welden
NPI 1588638472
$718.15
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $128 · 2021: $232 · 2022: $148 · 2024: $30.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $171.83 | 2019-2021 | |
| Abbvie INC. | $112.31 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.91 | 2019-2021 | |
| Amgen INC. | $77.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $30.87 | 2021-2022 | |
| Endogastric Solutions, INC | $30.01 | 2024 | Esophyx |
| Amarin Pharma, INC. | $27.65 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.44 | 2020-2022 | |
| Lilly USA, LLC | $22.85 | 2020 | |
| Novo Nordisk INC | $19.96 | 2021 | |
| Arbor Pharmaceuticals, INC. | $19.63 | 2020 | |
| Almatica Pharma LLC | $16.77 | 2022 | |
| Astellas Pharma US INC | $15.82 | 2021 | |
| Radius Health, INC. | $14.49 | 2021 | |
| Dexcom, INC. | $14.16 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.56 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.25 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Welden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.